SIRT1 and kidney disorder: Corroborating these findings, Zhang and co-workers (2019) showed that catalpol exhibits protective effects against adriamycin-induced nephropathy by increasing SIRT1 mRNA and protein levels and, consequently, decreasing pro-inflammatory cytokines, namely IL-6 and TNF-α, cellular ROS accumulation, and apoptosis.